It was also able to distinguish betweenpatients with hepatocellular carcinoma, patients with cirrhosis, andhealthy donors with remarkable accuracy, surpassing traditional clinicalindicators like the AST/ALT ratio, CEA, and AFP. The gene discussed is AFP; the disease is hepatocellular carcinoma.